Baker Bros. Advisors’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.7M | Hold |
4,865,819
| – | – | 0.32% | 30 |
|
|
2025
Q1 | $44M | Hold |
4,865,819
| – | – | 0.49% | 24 |
|
|
2024
Q4 | $84.1M | Hold |
4,865,819
| – | – | 0.9% | 16 |
|
|
2024
Q3 | $77.8M | Hold |
4,865,819
| – | – | 0.81% | 18 |
|
|
2024
Q2 | $69.3M | Hold |
4,865,819
| – | – | 0.89% | 19 |
|
|
2024
Q1 | $68.9M | Hold |
4,865,819
| – | – | 0.86% | 16 |
|
|
2023
Q4 | $73.4M | Hold |
4,865,819
| – | – | 0.84% | 14 |
|
|
2023
Q3 | $76.9M | Hold |
4,865,819
| – | – | 0.44% | 15 |
|
|
2023
Q2 | $73.7M | Hold |
4,865,819
| – | – | 0.43% | 19 |
|
|
2023
Q1 | $70.6M | Hold |
4,865,819
| – | – | 0.38% | 17 |
|
|
2022
Q4 | $65.8M | Hold |
4,865,819
| – | – | 0.4% | 19 |
|
|
2022
Q3 | $76.7M | Hold |
4,865,819
| – | – | 0.5% | 19 |
|
|
2022
Q2 | $59.3M | Buy |
4,865,819
+161,400
| +3% | +$1.97M | 0.34% | 19 |
|
|
2022
Q1 | $44.2M | Hold |
4,704,419
| – | – | 0.25% | 31 |
|
|
2021
Q4 | $80.5M | Buy |
+4,704,419
| New | +$80.5M | 0.39% | 23 |
|